WiLAN Reports 2016 First Quarter Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
WiLAN Reports 2016 First Quarter Financial Results

OTTAWA, CANADA--(Marketwired - April 27, 2016) - WiLAN (TSX:WIN)(NASDAQ:WILN) today reported financial results for the three months ended March 31, 2016. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

First Quarter 2016 Highlights

  • Revenues of $30.1 million
  • Revenues of $112.6 million for the trailing twelve month period
  • EBITDA* of $19.8 million, or $0.16 per basic share
  • EBITDA of $69.8 million for the trailing twelve month period
  • GAAP net earnings of $4.9 million, or $0.04 per basic share
  • Cash balance increased to $101.8 million at March 31, 2016
  • Returned $3.4 million to shareholders in dividend payments and buyback purchases
  • Signed 11 license agreements

"Our strong performance in Q1 reflects the continued execution of our partner and portfolio program strategy and our focus on closely managing expenses," said Jim Skippen, CEO of WiLAN. "We signed 11 licenses in the quarter including agreements with two of the top three semiconductor foundries in the world - TSMC and GlobalFoundries - which helped to drive our revenue growth. Our 65% EBITDA margin and cash flow generation in Q1 reflect the scalability and profitability in our model and its ability to deliver results over the long-term."

Approval of Eligible Dividend

The Board of Directors declared an eligible quarterly dividend of CDN $0.0125 per common share to be paid on July 7, 2016, to shareholders of record on June 13, 2016.

First Quarter 2016 Revenue Review

In the three month period ended March 31, 2016, WiLAN generated revenues of $30.1 million, compared with $20.4 million in the same period last year.

The increase in revenue is attributable to fixed payment license agreements signed during the three months ended March 31, 2016 partially offset by the completion of certain fixed payment license agreements signed in previous years.

First Quarter 2016 Operating Expense Review

Cost of revenue expenses

In the three month period ended March 31, 2016, cost of revenue totaled $17.9 million compared with $19.4 million in the same period last year.

The decrease in cost of revenue is primarily attributable to a decrease in litigation expense partially offset by an increase in patent maintenance, prosecution, and evaluation costs, contingent partner payments and legal fees, and amortization expense. In general, patent licensing expenses are proportional to the breadth and depth of our licensing programs and should be expected to increase as we add programs to our business operations.

Three months ended
March 31, 2016 March 31, 2015
Compensation and benefits $1,853 $1,992
Litigation 892 6,240
Patent maintenance, prosecution, and evaluation 3,048 1,344
Contingent partner payments and legal fees 1,928 655
Amortization of patents 10,022 8,845
Stock-based compensation 90 126
Other 159 264
$17,992 $19,466

For the three months ended March 31, 2016, litigation expenses amounted to $0.9 million compared with $6.2 million for the same period last year. The decrease in litigation expense for the three months ended March 31, 2016 is attributable to an increase in shared risk fee arrangements with external legal counsel in comparison to the same period last year.

Litigation expenses are expected to vary from period to period due to the variability of litigation activities and shared risk fee arrangements. We expect a decrease in litigation expenses in fiscal 2016 as a result of the expected level of litigation activities and corresponding fee arrangements.

Patent maintenance and prosecution expenses increased over the same period last year as a result of the increased number of patents and applications the Company currently maintains. The Company is actively working to reduce the number of non-core patents in its portfolio through a combination of strategic sales, lifetime licenses and, in certain cases, the abandonment or dedication to the public of several patents and applications.

Marketing, general, and administration expenses ("MG&A")

In the first quarter ended March 31, 2016, MG&A expenses amounted to $2.6 million, or 9% of revenue, compared with $2.2 million, or 11% of revenue, in the first quarter ended March 31, 2015. These costs will vary from period to period depending on the activities and initiatives undertaken at that time.

Three months ended
March 31, 2016 March 31, 2015
Compensation and benefits $1,302 $1,191
Depreciation 107 118
Stock-based compensation 17 116
Public company costs 700 315
Facilities 151 149
Other 370 397
$2,647 $2,251

Research and development expenses ("R&D")

The restructuring activities, which commenced in October 2015, resulted in the elimination of our R&D activities and, therefore, we do not expect to incur any expenses related to R&D. We do not expect the elimination of our R&D activities to have a material impact, if any, on our business activities.

Foreign Exchange

In the first quarter ended March 31, 2016, the Company incurred a foreign exchange gain of $0.2 million compared with a loss of $2.3 million in the first quarter ended March 31, 2015.

The unrealized foreign exchange gain of $0.2 million recognized in the three months ended March 31, 2016 resulted from the translation of monetary accounts, primarily cash and cash equivalents, short-term investments, dividends, and accounts payable, denominated in Canadian dollars to U.S. dollars. The change from last year is attributable to the decrease in the level of monetary accounts denominated in Canadian dollars and the Canadian dollar strengthening relative to the U.S. dollar.

EBITDA

In the first quarter ended March 31, 2016, WiLAN generated EBITDA of $19.8 million, or $0.16 per basic share, compared with $4.7 million, or $0.04 per basic share, in the same period last year. The growth in EBITDA reflected strong revenue performance in the quarter as well as the Company's ongoing efforts to closely manage expenses.

Net Earnings

WiLAN's GAAP earnings were $4.9 million, or $0.04 per basic share, in the three month period ended March 31, 2016 compared with a GAAP net loss of $4.7 million, or $0.04 per basic share, in the same period last year.

First Quarter 2016 Balance Sheet and Cash Flow Review

At March 31, 2016, the Company's cash, comprised of cash and cash equivalents and short-term investments, totaled $101.8 million, representing an increase of $7.3 million from the cash position at December 31, 2015. The increase is primarily attributable to $14.8 million of cash generated from operations, which was partially offset by the payment of dividends totaling $1.1 million, the repurchase of common shares under a normal course issuer bid totaling $2.3 million and patent acquisitions totaling $4.4 million which includes payments totaling $1.4 million for the repayment of patent finance obligations for patents acquired in 2013 and payments totaling $3.0 million for patents acquired in 2015.

Fiscal 2016 Financial Guidance

Cash operating expenses for the second quarter 2016 are expected to be in the range of $9.7 million to $11.0 million, of which $1.6 million to $2.1 million is expected to be litigation expense. These expenses exclude any contingent partner payments and contingent legal fees.

Conference Call Information - April 27, 2016 - 10:00 AM ET

WiLAN will conduct a conference call to discuss its financial results today at 10:00 AM Eastern Time. WiLAN CEO, Jim Skippen and CFO, Shaun McEwan will host the call.

Calling Information

A live audio webcast will be available at: http://www.gowebcasting.com/7493

  • To access the call from Canada and U.S., dial 1.877.291.4570 (Toll Free)
  • To access the call from other locations, dial 1.647.788.4919 (International)

Replay Information

The call will be available at http://www.gowebcasting.com/7493 and accessible by telephone until 11:59 PM ET on May 5, 2016.

Replay Number (Toll Free): 1.855.859.2056

Conference ID #: 90463308

About WiLAN

WiLAN is one of the most successful patent licensing companies in the world and helps companies unlock the value of intellectual property by managing and licensing their patent portfolios. The Company operates in a variety of markets including automotive, digital television, Internet, medical, semiconductor and wireless communication technologies. Founded in 1992, WiLAN is listed on the TSX and NASDAQ. For more information: www.wilan.com .

Non-GAAP Disclosure*

WiLAN follows U.S.GAAP in preparing its interim and annual financial statements. We use the term "EBITDA" to reference Earnings Before Interest, Taxes, Depreciation and Amortization. EBITDA are earnings from continuing operations before interest income, interest expense, depreciation expense, amortization expense, and the provision for (recovery of) income taxes as disclosed in the reconciliation of GAAP net earnings to EBITDA included in this press release. We report EBITDA in the belief that it may be useful for certain investors and readers of the financial statements as a measure of our performance. EBITDA IS NOT A MEASURE OF FINANCIAL PERFORMANCE UNDER U.S. GAAP. IT DOES NOT HAVE ANY STANDARDIZED MEANING PRESCRIBED BY U.S. GAAP AND IS THEREFORE UNLIKELY TO BE COMPARABLE TO SIMILARLY TITLED MEASURES USED BY OTHER COMPANIES. EBITDA SHOULD NOT BE INTERPRETED AS AN ALTERNATIVE TO NET EARNINGS AND CASH FLOWS FROM OPERATIONS AS DETERMINED IN ACCORDANCE WITH U.S. GAAP OR AS A MEASURE OF LIQUIDITY.

Forward-looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other United States and Canadian securities laws. The phrases "reflect the scalability and profitability in our model and its ability to deliver results over the long-term", "should be expected to increase", "we expect a decrease", "the Company is actively working to reduce", "we do not expect", "are expected to be", "is expected to be" and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements and forward-looking information are based on estimates and assumptions made by WiLAN in light of its experience and its perception of historical trends, current conditions, expected future developments and the expected effects of new business strategies, as well as other factors that WiLAN believes are appropriate in the circumstances. Many factors could cause WiLAN's actual performance or achievements to differ materially from those expressed or implied by the forward-looking statements or forward-looking information. Such factors include, without limitation, the risks described in WiLAN's February 8, 2016 annual information form for the year en ded December 31, 2015 (the "AIF"). Copies of the AIF may be obtained at www.sedar.com or www.sec.gov . WiLAN recommends that readers review and consider all of these risk factors and notes that readers should not place undue reliance on any of WiLAN's forward-looking statements. WiLAN has no intention and undertakes no obligation to update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Financial guidance is provided to assist investors and other interested parties in understanding WiLAN's performance. The reader is cautioned that using this information for any other purpose may be inappropriate.

The above targets reflect our current business indicators and expectations and are subject to fluctuations in foreign currency exchange rates. Due to their nature, certain expense items, such as new litigation actions, contingent payments to licensing partners and litigation counsel that may be required from certain licenses signed in any particular quarter, losses on asset impairments or realized foreign exchange losses cannot be accurately forecast. Accordingly, we exclude forecasts of such items from our guidance. Actual expenses incurred may exceed the expense guidance provided due, in part, to contingent payments to licensing partners and litigation counsel that may be required from certain licenses signed during the quarter.

Actual results may vary materially from the guidance provided as a consequence of the above noted factors.

All trademarks and brands mentioned in this release are the property of their respective owners.

Wi-LAN Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(in thousands of United States dollars, except share and per share amounts)
Three months ended Three months ended
March 31, 2016 March 31, 2015
Revenue $ 30,160 $ 20,410
Operating expenses
Cost of revenue 17,992 19,466
Research and development - 719
Marketing, general and administration 2,647 2,251
Foreign exchange (gain) loss (163 ) 2,286
Total operating expenses 20,476 24,722
Earnings (loss) from operations 9,684 (4,312 )
Interest income 118 122
Earnings (loss) before income taxes 9,802 (4,190 )
Provision for (recovery of) income tax expense
Current 3,023 1,003
Deferred 1,859 (435 )
4,882 568
Net earnings (loss) 4,920 (4,758 )
Net and comprehensive earnings (loss) $ 4,920 $ (4,758 )
Earnings (loss) per share
Basic $ 0.04 $ (0.04 )
Diluted $ 0.04 $ (0.04 )
Weighted average number of common shares
Basic 120,281,998 120,472,290
Diluted 120,281,998 120,472,290
Wi-LAN Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(in thousands of United States dollars)
As at March 31, 2016 December 31, 2015
Current assets
Cash and cash equivalents $ 100,685 $ 93,431
Short-term investments 1,194 1,120
Accounts receivable 11,011 8,436
Prepaid expenses and deposits 1,581 1,607
114,471 104,594
Loan receivable 1,561 1,497
Furniture and equipment, net 1,509 1,614
Patents and other intangibles, net 145,402 155,213
Deferred tax asset 15,818 17,677
Goodwill 12,623 12,623
$ 291,384 $ 293,218
Current liabilities
Accounts payable and accrued liabilities $ 21,327 $ 23,205
Current portion of patent finance obligation 10,152 8,085
31,479 31,290
Patent finance obligation 16,652 19,895
Success fee obligation 187 655
48,318 51,840
Shareholders' equity
Capital stock 422,712 427,781
Additional paid-in capital 19,455 16,549
Accumulated other comprehensive income 16,225 16,225
Deficit (215,326 ) (219,177 )
243,066 241,378
$ 291,384 $ 293,218
Wi-LAN Inc.
Condensed Consolidated Statements of Cash Flow
(Unaudited)
(in thousands of United States dollars)
Three months ended Three months ended
March 31, 2016 March 31, 2015
Cash generated from (used in)
Operations
Net earnings (loss) $ 4,920 $ (4,758 )
Non-cash items
Stock-based compensation 108 272
Depreciation and amortization 10,130 8,988
Foreign exchange (gain) loss (285 ) 753
Disposal of assets 13 -
Deferred income tax expense (recovery) 1,859 (435 )
Accrued investment income (64 ) (55 )
Change in non-cash working capital balances
Accounts receivable (2,575 ) 1,297
Prepaid expenses and deposits 26 (721 )
Payments associated with success fee obligation (854 ) (1,174 )
Accounts payable and accrued liabilities 1,531 (1,806 )
Cash generated from operations 14,809 2,361
Financing
Dividends paid (1,091 ) (5,183 )
Common shares repurchased under normal course issuer bid (2,271 ) (329 )
Common shares issued for cash on the exercise of options - 1,269
Cash used in financing (3,362 ) (4,243 )
Investing
Purchase of furniture and equipment (16 ) (28 )
Repayment of patent finance obligations (1,388 ) (5,532 )
Purchase of patents (3,000 ) (1,000 )
Cash used in investing (4,404 ) (6,560 )
Foreign exchange gain (loss) on cash held in foreign currency 211 (641 )
Net cash and cash equivalents generated (used) in the period 7,254 (9,083 )
Cash and cash equivalents, beginning of period 93,431 126,311
Cash and cash equivalents, end of period $ 100,685 $ 117,228
Wi-LAN Inc.
Condensed Consolidated Statement of Shareholders' Equity
(Unaudited)
(in thousands of United States dollars)
Capital Stock Additional Paid-in Capital Accumulated Other Comprehensive Income Deficit Total Equity
Balance - December 31, 2014 $ 426,037 $ 16,375 $ 16,225 $ (212,880 ) $ 245,757
Comprehensive loss:
Net loss - - - (4,758 ) (4,758 )
Shares and options issued:
Stock-based compensation expense - 272 - - 272
Exercise of stock options 2,056 (787 ) - - 1,269
Shares repurchased under normal course issuer bid (443 ) 114 - - (329 )
Dividends declared - - - (5,102 ) (5,102 )
Balance - March 31, 2015 $ 427,650 $ 15,974 $ 16,225 $ (222,740 ) $ 237,109
Balance - December 31, 2015 $ 427,781 $ 16,549 $ 16,225 $ (219,177 ) $ 241,378
Comprehensive earnings:
Net earnings - - - 4,920 4,920
Shares and options issued:
Stock-based compensation expense - 108 - - 108
Shares repurchased under normal course issuer bid (5,069 ) 2,798 - - (2,271 )
Dividends declared - - - (1,069 ) (1,069 )
Balance - March 31, 2016 $ 422,712 $ 19,455 $ 16,225 $ (215,326 ) $ 243,066
Wi-LAN Inc.
Reconciliation of GAAP Net Earnings to EBITDA
(in thousands of United States dollars, except share and per share amounts)
Three months ended
March 31, 2016 March 31, 2015
Net earnings (loss) under GAAP $ 4,920 $ (4,758 )
Adjusted for:
Interest income (118 ) (122 )
Depreciation and amortization 10,130 8,988
Income tax expense 4,882 568
EBITDA $ 19,814 $ 4,676
Weighted average number of common shares (1)
Basic 120,281,998 120,472,290
EBITDA per basic share $ 0.16 $ 0.04
Earnings (loss) per basic share under GAAP $ 0.04 $ (0.04 )

1. Weighted average number of common shares used in the calculation of EBITDA per basic share and earnings per basic share under GAAP.

For media and investor inquiries, please contact: Shaun McEwan Chief Financial Officer O: 613.688.4898 C: 613.697.7159 smcewan@wilan.com Dave Mason Investor Relations 613.688.1693 dave.mason@loderockadvisors.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 139

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 184

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 168

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 108

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 79

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading

Top 5 Most Recently Viewed Articles

James Lukezic's Triumph: FINRA Case Dismissed, Reputation Restored

Updated Category News Views 278

James Lukezic's Journey to Exoneration NEW YORK – After undergoing extensive hearings, James Lukezic, the Managing Principal of Old Slip Capital Management, has successfully cleared his name of unfounded allegations in a substantial FINRA case. This decision represents a significant milestone for Lukezic, who faced serious accusations surrounding five trades that...

Continue Reading
DraftKings Inc. Reports Impressive Q2 Growth and Strong Future Prospects

Updated Category News Views 175

DraftKings Inc. Achieves Record Revenue in Q2 DraftKings Inc. announced remarkable financial results for the second quarter, showcasing a significant leap in its performance. This includes a record revenue of $1.51 billion, representing a 37% increase year-over-year. This impressive growth surpassed analyst expectations, as the consensus estimate was only $1.39 billion....

Continue Reading
Trellis Bioscience's $9M Shot at Revolutionizing PJI Treatment

Updated Category News Views 40

New Hope on the Horizon for Joint Implant Infections When you hear about prosthetic joint infections (PJIs), 'devastating' doesn’t quite cover it. We’re talking something that’s hard to tackle, ends up costlier than a Beverly Hills tax bill, and drains quality of life like nothing else. Now, Trellis Bioscience seems to think there's hope on the way. The company just...

Continue Reading
Dionisio Gutiérrez Honored with Prestigious Award by Spain's King

Updated Category News Views 196

Dionisio Gutiérrez's Recognition and Achievements Dionisio Gutiérrez, a prominent figure known for his contributions to civic and business advancements, has recently been honored with the XI Enrique V. Iglesias Award. This prestigious accolade, presented by King Felipe VI of Spain, acknowledges Gutiérrez's significant impact within the Ibero-American space,...

Continue Reading
Vivani Medical Advances in Clinical Trials for GLP-1 Implant

Updated Category News Views 238

Vivani Medical, Inc. (NASDAQ: VANI) recently received approval from the Bellberry Human Research Ethics Committee and an acknowledgment from Australia’s Therapeutic Goods Administration for its first-in-human clinical trial. This significant step centers around the company's innovative GLP-1 (exenatide) implant targeting overweight and obese individuals, marking a...

Continue Reading